Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Venus Medtech (Hangzhou) Inc. per 2025 Jun 30 adalah 427.25 MM.
- Nilai operating income untuk Venus Medtech (Hangzhou) Inc. per 2025 Jun 30 adalah -296.84 MM.
- Nilai net income untuk Venus Medtech (Hangzhou) Inc. per 2025 Jun 30 adalah -642.59 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 427.25 | -296.84 | -642.59 |
2025-03-31 | 449.04 | -331.23 | -678.45 |
2024-12-31 | 470.83 | -365.62 | -714.31 |
2024-09-30 | 468.66 | -410.89 | -637.18 |
2024-06-30 | 466.48 | -455.38 | -560.05 |
2024-03-31 | 478.93 | -521.57 | -631.90 |
2023-12-31 | 491.37 | -588.54 | -703.75 |
2023-09-30 | 471.74 | -680.60 | -955.85 |
2023-06-30 | 452.11 | -772.66 | -1,207.95 |
2023-03-31 | 429.28 | -722.42 | -1,132.83 |
2022-12-31 | 406.46 | -672.19 | -1,057.70 |
2022-09-30 | 396.51 | -564.28 | -759.10 |
2022-06-30 | 386.56 | -456.38 | -460.51 |
2022-03-31 | 401.21 | -369.10 | -417.07 |
2021-12-31 | 415.86 | -281.83 | -373.64 |
2021-09-30 | 414.56 | -226.91 | -312.58 |
2021-06-30 | 413.27 | -172.00 | -251.53 |
2021-03-31 | 344.66 | -175.28 | -216.76 |
2020-12-31 | 276.05 | -178.56 | -181.99 |
2020-09-30 | 251.97 | -199.50 | -210.24 |
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | -1.28 | -1.28 |
2024-03-31 | -1.44 | -1.44 |
2023-12-31 | -1.61 | |
2023-09-30 | -2.18 | -2.18 |
2023-06-30 | -2.76 | -2.76 |
2023-03-31 | -2.59 | -2.59 |
2022-12-31 | -2.42 | |
2022-09-30 | -1.73 | -1.73 |
2022-06-30 | -1.05 | -1.05 |
2022-03-31 | -0.95 | -0.95 |
2021-12-31 | -0.85 | |
2021-09-30 | -0.72 | -0.72 |
2021-06-30 | -0.59 | -0.59 |
2021-03-31 | -0.52 | -0.52 |
2020-12-31 | -0.44 | |
2020-09-30 | -0.50 | -0.50 |
2020-03-31 | -0.77 | -0.77 |
Arus Kas: Operasi, Investasi, Pendanaan
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | 23.74 | -19.90 | -487.34 |
2024-09-30 | -103.82 | -127.60 | -463.29 |
2024-06-30 | -231.38 | -235.30 | -439.25 |
2024-03-31 | -420.70 | -291.08 | -306.62 |
2023-12-31 | -610.02 | -346.86 | -173.99 |
2023-09-30 | -685.84 | -34.57 | -231.98 |
2023-06-30 | -761.66 | 277.72 | -289.97 |
2023-03-31 | -745.56 | -397.27 | 172.59 |
2022-12-31 | -729.46 | -1,072.27 | 635.14 |
2022-09-30 | -622.14 | -1,556.39 | 837.73 |
2022-06-30 | -514.82 | -2,040.51 | 1,040.31 |
2022-03-31 | -485.87 | -1,346.77 | 1,215.86 |
2021-12-31 | -456.92 | -653.04 | 1,391.40 |
2021-09-30 | -389.62 | -425.74 | 1,821.10 |
2021-06-30 | -322.33 | -198.43 | 2,250.81 |
2021-03-31 | -279.67 | -248.19 | 1,589.28 |
2020-12-31 | -237.00 | -297.94 | 927.75 |
2020-09-30 | -250.43 | -264.02 | 1,504.44 |
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Venus Medtech (Hangzhou) Inc. pada 2025 Jun 30 adalah -0.18.
- roe untuk Venus Medtech (Hangzhou) Inc. pada 2025 Jun 30 adalah -0.26.
- roic untuk Venus Medtech (Hangzhou) Inc. pada 2025 Jun 30 adalah -0.28.
- croic untuk Venus Medtech (Hangzhou) Inc. pada 2025 Jun 30 adalah -0.18.
- ocroic untuk Venus Medtech (Hangzhou) Inc. pada 2025 Jun 30 adalah 0.01.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.18 | -0.26 | -0.28 | -0.18 | 0.01 |
2025-03-31 | -0.18 | -0.26 | -0.28 | 0.00 | 0.00 |
2024-12-31 | -0.13 | -0.19 | -0.17 | -0.26 | -0.07 |
2024-09-30 | -0.13 | -0.19 | -0.17 | -0.26 | -0.07 |
2024-06-30 | -0.19 | ||||
2024-03-31 | -0.20 | ||||
2023-12-31 | -0.32 | -0.29 | |||
2023-09-30 | -0.35 | -0.20 | |||
2023-06-30 | -0.27 | ||||
2023-03-31 | -0.25 | ||||
2022-12-31 | |||||
2022-09-30 | 0.00 | ||||
2022-06-30 | 0.00 | 0.00 | |||
2022-03-31 | 0.00 | ||||
2021-12-31 | 0.00 | ||||
2021-09-30 | -0.07 | -0.08 | |||
2021-06-30 | -0.07 | -0.05 | 0.32 | -0.07 | |
2021-03-31 | -0.06 | -0.07 | -0.04 | 0.19 | -0.06 |
2020-12-31 | -0.05 | -0.06 | -0.05 | 0.08 | -0.06 |
2020-09-30 | -0.06 | -0.07 | -0.05 | 0.24 | -0.06 |
2020-03-31 | -0.30 | -0.66 | -0.10 | 0.61 | -0.09 |
Gross Margins
- marjin kotor untuk Venus Medtech (Hangzhou) Inc. pada 2025 Jun 30 adalah 0.78.
- marjin bersih untuk Venus Medtech (Hangzhou) Inc. pada 2025 Jun 30 adalah -1.52.
- marjin operasi untuk Venus Medtech (Hangzhou) Inc. pada 2025 Jun 30 adalah -0.78.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.78 | -1.52 | -0.78 |
2025-03-31 | 0.78 | -1.52 | -0.82 |
2024-12-31 | 0.79 | -1.20 | -0.98 |
2024-09-30 | 0.79 | -1.20 | -0.98 |
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | -2.67 | -1.71 | |
2023-06-30 | -2.67 | -1.71 | |
2023-03-31 | -2.64 | -1.68 | |
2022-12-31 | |||
2022-09-30 | 0.00 | 0.00 | |
2022-06-30 | 0.00 | 0.00 | |
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | 0.80 | -0.61 | -0.41 |
2021-03-31 | 0.81 | -0.63 | -0.50 |
2020-12-31 | 0.82 | -0.66 | -0.65 |
2020-09-30 | 0.83 | -0.83 | -0.75 |
2020-03-31 | 0.84 | -1.34 | -1.23 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |